288 related articles for article (PubMed ID: 30390673)
1. Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes.
Starhof C; Winge K; Heegaard NHH; Skogstrand K; Friis S; Hejl A
J Neuroinflammation; 2018 Nov; 15(1):305. PubMed ID: 30390673
[TBL] [Abstract][Full Text] [Related]
2. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
[TBL] [Abstract][Full Text] [Related]
3. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
[TBL] [Abstract][Full Text] [Related]
5. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
[TBL] [Abstract][Full Text] [Related]
6. Manual MRI morphometry in Parkinsonian syndromes.
Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
[TBL] [Abstract][Full Text] [Related]
7. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
[TBL] [Abstract][Full Text] [Related]
8. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
[TBL] [Abstract][Full Text] [Related]
9. Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.
Constantinides VC; Paraskevas GP; Stamboulis E; Kapaki E
Neurol Sci; 2018 Feb; 39(2):359-364. PubMed ID: 29196955
[TBL] [Abstract][Full Text] [Related]
10. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study.
Compta Y; Dias SP; Giraldo DM; Pérez-Soriano A; Muñoz E; Saura J; Fernández M; Bravo P; Cámara A; Pulido-Salgado M; Painous C; Ríos J; Martí MJ;
Parkinsonism Relat Disord; 2019 Aug; 65():3-12. PubMed ID: 31178335
[TBL] [Abstract][Full Text] [Related]
12. Early strong intrathecal inflammation in cerebellar type multiple system atrophy by cerebrospinal fluid cytokine/chemokine profiles: a case control study.
Yamasaki R; Yamaguchi H; Matsushita T; Fujii T; Hiwatashi A; Kira JI
J Neuroinflammation; 2017 Apr; 14(1):89. PubMed ID: 28438224
[TBL] [Abstract][Full Text] [Related]
13. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
14. Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting.
Chougar L; Faouzi J; Pyatigorskaya N; Yahia-Cherif L; Gaurav R; Biondetti E; Villotte M; Valabrègue R; Corvol JC; Brice A; Mariani LL; Cormier F; Vidailhet M; Dupont G; Piot I; Grabli D; Payan C; Colliot O; Degos B; Lehéricy S
Mov Disord; 2021 Feb; 36(2):460-470. PubMed ID: 33137232
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
[TBL] [Abstract][Full Text] [Related]
16. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
[TBL] [Abstract][Full Text] [Related]
17. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A
Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659
[TBL] [Abstract][Full Text] [Related]
18. Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism.
Chougar L; Arsovic E; Gaurav R; Biondetti E; Faucher A; Valabrègue R; Pyatigorskaya N; Dupont G; Lejeune FX; Cormier F; Corvol JC; Vidailhet M; Degos B; Grabli D; Lehéricy S
Mov Disord; 2022 Jun; 37(6):1245-1255. PubMed ID: 35347754
[TBL] [Abstract][Full Text] [Related]
19. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
[TBL] [Abstract][Full Text] [Related]
20. CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes.
Constantinides VC; Paraskevas GP; Emmanouilidou E; Petropoulou O; Bougea A; Vekrellis K; Evdokimidis I; Stamboulis E; Kapaki E
J Neurol Sci; 2017 Nov; 382():91-95. PubMed ID: 29111028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
